🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 69353Y103
- IPO
- 9/25/2020 · $18.00/share
Business: PMV Pharmaceuticals, Inc. is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 mutations.
Company Contact
- CEO
- David H. Mack
- CFO
- Michael Carulli
- Headquarters
- 400 Alexander Park Drive, Suite 301, Princeton, NJ 08540
- Phone
- 609-642-6670
- Investor Relations
- Winston Kung · 609-642-6670 · investors@pmvpharma.com